Professor Mimoun Azzouz

Academic Founder, Chief Scientific Officer and Chair of Advisory Board. Chair of Translational Neuroscience at the University of Sheffield. Director of Gene Therapy Innovation & Manufacturing Centre (GTIMC). Former Director of Neurobiology at Oxford Biomedica.

Peter Nolan

Founder, Chair and Interim CEO. Former Director, Chief Business Officer and key executive of Oxford Biomedica since its inception. Over 25 years of experience in gene therapy commercialisation, leading negotiations on critical deals such as Novartis and Sanofi.

Chris Edwards

Founder and Chief Business Officer. Seasoned entrepreneur with 20 years of experience founding new ventures.

Darren Cunningham

CFO. 25 years experience within the biopharma industry; business development; fundraising. Co-founder and former CEO of two therapeutic biotechs.

Kathleen Kirby

Development Operations. Kathleen brings extensive experience in Development Operations and Program Management in Gene Therapy clinical trials, with an emphasis on rare neurodevelopmental disorders in pediatric populations.

Darius Ebrahimi-Fakhari
MD, PhD

Director, Hereditary Spastic Paraplegia Research Program; attending Neurologist and Assistant Professor, Boston Children’s Hospital & Harvard Medical School.

Prof. Manju Kurian
MA MBBChir MRCPCH PhD

Professor of Neurogenetics and an NIHR Research Professor at UCL-Great Ormond Street Institute of Child Health, UK. Consultant Paediatric Neurologist at Great Ormond Street Hospital.

Prof. Stephane Palfi
MD, PhD

Professor of Neurosurgery and Head of the Neurosurgical Department at Henri Mondor Medical Center, Paris University (UPEC).

PROF. ROGER BARKER
PhD

Professor of Neurosurgery and Head of the Neurosurgical Department at Henri Mondor Medical Center, Paris University (UPEC).